Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report.
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis.
Microbial colonization influences early B-lineage development in the gut lamina propria.
Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
Sublime Microglia: Expanding Roles for the Guardians of the CNS.
From "Wheelchair Circuit" to "Wheelchair Assessment Instrument for People with Multiple Sclerosis": Reliability and Validity Analysis of a Test to Assess Driving Skills in Manual Wheelchair Users With Multiple Sclerosis.
Information on natalizumab (marketed as Tysabri)
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial.
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.
CD4 cell response to interval therapy with natalizumab.
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Oligodendrocytes and the early multiple sclerosis lesion.
Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".
Unraveling the secrets of white matter - Bridging the gap between cellular, animal and human imaging studies.
Decreased Frontal Lobe Gray Matter Perfusion in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis Detected by the Bookend Technique.
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis.
Evaluation of sexual function in women at two stages of multiple sclerosis.
Teva to initiate third Phase III trial of oral laquinimod for the treatment of relapsing remitting multiple sclerosis
Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis.
Motor impairments at presentation of clinically isolated syndrome suggestive of multiple sclerosis: Characterization of different disease subtypes.
Nerve Conduction Velocity Is Regulated by the Inositol Polyphosphate-4-Phosphatase II Gene.
Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis.
Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial.

Pages